Monash IVF Group Limited (ASX:MVF)
0.7050
-0.0050 (-0.70%)
Feb 4, 2026, 4:13 PM AEST
Monash IVF Group Revenue
In the fiscal year ending June 30, 2025, Monash IVF Group had annual revenue of 271.92M AUD with 6.54% growth. Monash IVF Group had revenue of 131.53M in the half year ending June 30, 2025, with 19.06% growth.
Revenue
271.92M
Revenue Growth
+6.54%
P/S Ratio
1.01
Revenue / Employee
304.84K
Employees
892
Market Cap
274.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 271.92M | 16.69M | 6.54% |
| Jun 30, 2024 | 255.23M | 41.43M | 19.38% |
| Jun 30, 2023 | 213.80M | 21.50M | 11.18% |
| Jun 30, 2022 | 192.29M | 8.69M | 4.73% |
| Jun 30, 2021 | 183.61M | 38.19M | 26.26% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sonic Healthcare | 9.65B |
| Healius | 1.34B |
| Australian Clinical Labs | 741.27M |
| Integral Diagnostics | 627.22M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Cryosite | 14.12M |
| Rhythm Biosciences | 3.19M |